New Delhi, Dec 9
The Central Drugs Standard Control Organization (CDSCO) has granted regulatory approval to SSI Mantra, the first made-in-India surgical robotic system, for telesurgery and teleproctoring, signifying a monumental leap in surgical robotics, the company said on Monday.
Developed by Gurugram-based SS Innovations, the system aims to decentralise and democratise access to surgical expertise. It also addresses critical gaps in healthcare, particularly in remote areas, where access to specialised medical care has often been a challenge.
“Telesurgery and teleproctoring have been a dream in the making for over four decades, and today, it has finally come to life. With the technology and bandwidth available now, we can truly decentralise and democratise surgical expertise, reaching patients and surgeons in the most remote parts of India and the world,” said Dr. Sudhir Srivastava, SS Innovations Founder, Chairman, and CEO.
“This innovation is a game-changer, especially for our country, where much of the population lives in smaller towns and rural areas. By enabling remote surgical intervention, we are reshaping the future of healthcare,” he added.